BioElectron Technology Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Employees
-
45
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$210M
BioElectron Technology General Information
Description
Developer of redox drugs designed to discover new approaches to human health and disease. The company's redox drugs detects defects in the mitochondrial proteins, enabling healthcare professionals to treat mitochondrial diseases are genetic disorders.
Contact Information
Website
www.bioelectron.comCorporate Office
- 350 North Bernardo Avenue
- Mountain View, CA 94043
- United States
Corporate Office
- 350 North Bernardo Avenue
- Mountain View, CA 94043
- United States
BioElectron Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 25-Oct-2019 | $210M | Completed | Profitable | ||
| 8. Debt - General | 10-Aug-2018 | Completed | Profitable | |||
| 7. Later Stage VC (Series G) | 27-Mar-2014 | Completed | Profitable | |||
| 6. Later Stage VC (Series F) | 26-Nov-2012 | Completed | Profitable | |||
| 5. Later Stage VC (Series E) | 31-Aug-2011 | Completed | Profitable | |||
| 4. Later Stage VC (Series D) | 15-Apr-2010 | Completed | Profitable | |||
| 3. Later Stage VC (Series C) | 22-Apr-2009 | Completed | Profitable | |||
| 2. Early Stage VC (Series B) | 02-Aug-2007 | $4.87M | $7.67M | Completed | Profitable | |
| 1. Early Stage VC (Series A) | 22-Nov-2005 | $2.8M | $2.8M | Completed | Profitable |
BioElectron Technology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
BioElectron Technology Comparisons
Industry
Financing
Details
BioElectron Technology Competitors (43)
One of BioElectron Technology’s 43 competitors is Casma Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Casma Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| Recyte Therapeutics | Formerly VC-backed | Alameda, CA | ||||
| Unity Biotechnology | Formerly VC-backed | South San Francisco, CA | ||||
| Oisin Biotechnologies | Venture Capital-Backed | Seattle, WA | ||||
| PAQ Therapeutics | Venture Capital-Backed | Cambridge, MA |
BioElectron Technology Patents
BioElectron Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018191732-A1 | Methods and compositions for treatment of inflammation and oxidative stress | Inactive | 14-Apr-2017 | ||
| US-20180333389-A1 | Vitamin e compositions and methods of use therefor | Inactive | 14-Apr-2017 | ||
| WO-2018129411-A1 | Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders | Inactive | 06-Jan-2017 | ||
| WO-2018093957-A1 | 2-substituted amino-naphth[1,2-d]imidazol-5-one compounds or pharmaceutically acceptable salts thereof cross reference to related applications | Inactive | 15-Nov-2016 | ||
| JP-2018083799-A | 2-substituted amino-naphtho[1,2-d]imidazole-5-one compound or pharmaceutically allowable salts thereof | Pending | 15-Nov-2016 | C07D233/88 |
BioElectron Technology Signals
BioElectron Technology Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Berg and Berg Enterprises | Venture Capital | Minority | ||
| Mitsui Global Investment | Venture Capital | Minority | ||
| Morningside Group | Venture Capital | Minority | ||
| Sumitomo Pharma | Corporation |
BioElectron Technology FAQs
-
When was BioElectron Technology founded?
BioElectron Technology was founded in 2005.
-
Where is BioElectron Technology headquartered?
BioElectron Technology is headquartered in Mountain View, CA.
-
What is the size of BioElectron Technology?
BioElectron Technology has 45 total employees.
-
What industry is BioElectron Technology in?
BioElectron Technology’s primary industry is Drug Discovery.
-
Is BioElectron Technology a private or public company?
BioElectron Technology is a Private company.
-
What is the current valuation of BioElectron Technology?
The current valuation of BioElectron Technology is .
-
What is BioElectron Technology’s current revenue?
The current revenue for BioElectron Technology is .
-
How much funding has BioElectron Technology raised over time?
BioElectron Technology has raised $128M.
-
Who are BioElectron Technology’s investors?
Berg and Berg Enterprises, Mitsui Global Investment, Morningside Group, and Sumitomo Pharma have invested in BioElectron Technology.
-
Who are BioElectron Technology’s competitors?
Casma Therapeutics, Recyte Therapeutics, Unity Biotechnology, Oisin Biotechnologies, and PAQ Therapeutics are some of the 43 competitors of BioElectron Technology.
-
When was BioElectron Technology acquired?
BioElectron Technology was acquired on 25-Oct-2019.
-
Who acquired BioElectron Technology?
BioElectron Technology was acquired by PTC Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process